-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 16, Inworld Biotech announced that the company's focal adhesion kinase (FAK) inhibitor IN10018 for the treatment of platinum-resistant ovarian cancer has been approved by the US FDA for fast track
Ovarian cancer is the second most common cause of female gynecological cancer mortality in the world.
Note: The original text has been deleted